Cypermethrin

DB13721InvestigationalSmall molecule

Cypermethrin is a medication used to treat parasitic skin diseases.

Mechanism: Pharmacologically active on Androgen receptor and Protein phosphatase 3 catalytic subunit alpha
Curator reviewed
Formula / weight: C₂₂H₁₉Cl₂NO₃ · 416.297 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyKAATUXNTWXVJKI-UHFFFAOYSA-NSMILESCC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1

Targets

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Structured indicationCondition, population, route and combination as fields, not prose

2ContraindicationsEach with its own population and attribute set

18Marketed productsAcross 1 country and 6 labellers

1ATC codeIncluding every combination product, plus 12 drug categories

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cypermethrin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.